These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 631328

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Solubilisation of high-affinity dopamine receptors.
    Gorissen H, Laduron P.
    Nature; 1979 May 03; 279(5708):72-4. PubMed ID: 450076
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S.
    Experientia; 1981 May 03; 37(9):1008-9. PubMed ID: 7297644
    [Abstract] [Full Text] [Related]

  • 25. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
    Trulson ME, Crisp T.
    Eur J Pharmacol; 1985 Nov 05; 117(2):267-70. PubMed ID: 4076345
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.
    Welch MJ, Kilbourn MR, Mathias CJ, Mintun MA, Raichle ME.
    Life Sci; 1983 Oct 24; 33(17):1687-93. PubMed ID: 6633162
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 24; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 31. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
    Antkiewicz-Michaluk L, Rokosz-Pelc A, Vetulani J.
    Pol J Pharmacol Pharm; 1985 Nov 24; 37(3):317-23. PubMed ID: 4070080
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ, Beart PM.
    Eur J Pharmacol; 1984 Oct 30; 106(1):133-9. PubMed ID: 6241565
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S, Paulose CS, Mishra RK.
    Science; 1981 Dec 11; 214(4526):1261-2. PubMed ID: 6117947
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.